Stocks and Finance

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals 1/10/2012

11:14 : Regeneron Pharmaceuticals ([[REGN]] +13.1%) CEO Len Schleifer gives an ... - Regeneron Pharmaceuticals (REGN +13.1%) CEO Len Schleifer gives an interesting peak under the hood in an earnings CC on how big pharma deals with the sticky issue of how to motivate doctors to load up on drug inventory ...
Source : seekingalpha-com

Regeneron Pharmaceuticals 10/17/2011

18:25 : Regeneron Pharmaceuticals (REGN) announces a private placement offering ... - Regeneron Pharmaceuticals (REGN) announces a private placement offering $400M of convertible senior notes due in 2016. Shares -4.8% AH. Post your comment!
Source : seekingalpha-com

Regeneron Pharmaceuticals 10/12/2011

10:51 : Regeneron Pharmaceuticals ([[REGN]] -1%) trades lower after Bloomberg ... - Regeneron Pharmaceuticals (REGN -1%) trades lower after Bloomberg REGN)+Shares+Tumble+Below+$65,+Bloomberg+Says+Avastin+May+Be+Rewarded+by+US+Govt+Amid+Lower+Cost/6851141.html">reports Roche's Avastin drug, a rival to ...
Source : seekingalpha-com

Regeneron Pharmaceuticals 9/2/2011

13:54 : Shares of Regeneron Pharmaceuticals ([[REGN]] +7.8%) are higher today ... - Shares of Regeneron Pharmaceuticals (REGN +7.8%) are higher today on the news of rival Roche's Avastin problems. Its own macular degeneration treatment Eylea, which competes with Avastin, is currently awaiting FDA approval. ...
Source : seekingalpha-com

Regeneron Pharmaceuticals 8/17/2011

13:35 : Regeneron Pharmaceuticals ([[REGN]] -4.7%) shares are lower after the ... - Regeneron Pharmaceuticals (REGN -4.7%) shares are lower after the FDA pushes back its review for the company's eye drug Eylea by three months. BofA Merrill Lynch cut its rating ...
Source : seekingalpha-com
actualidad Regeneron Pharmaceuticals -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts